首页 > 最新文献

Bjog-An International Journal of Obstetrics and Gynaecology最新文献

英文 中文
Differences in Factors Associated With Preterm and Term Stillbirth: A Secondary Cohort Analysis of the DESiGN Trial 早产和足月死胎相关因素的差异:DESiGN试验的二级队列分析。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-18 DOI: 10.1111/1471-0528.17951
Chivon Winsloe, James Elhindi, Matias C. Vieira, Sophie Relph, Charles G. Arcus, Alessandro Alagna, Annette Briley, Mark Johnson, Louise M. Page, Andrew Shennan, Baskaran Thilaganathan, Neil Marlow, Christoph Lees, Deborah A. Lawlor, Asma Khalil, Jane Sandall, Andrew Copas, Dharmintra Pasupathy, the DESiGN Trial team
<div> <section> <h3> Objective</h3> <p>To identify whether maternal and pregnancy characteristics associated with stillbirth differ between preterm and term stillbirth.</p> </section> <section> <h3> Design</h3> <p>Secondary cohort analysis of the DESiGN RCT.</p> </section> <section> <h3> Setting</h3> <p>Thirteen UK maternity units.</p> </section> <section> <h3> Population</h3> <p>Singleton pregnant women and their babies.</p> </section> <section> <h3> Methods</h3> <p>Multiple logistic regression was used to assess whether the 12 factors explored were associated with stillbirth. Interaction tests assessed for a difference in these associations between the preterm and term periods.</p> </section> <section> <h3> Main Outcome Measure</h3> <p>Stillbirth stratified by preterm (<37<sup>+0</sup> weeks') and term (37<sup>+0</sup>–42<sup>+6</sup> weeks') births.</p> </section> <section> <h3> Results</h3> <p>A total of 195 344 pregnancies were included. Six hundred and sixty-seven were stillborn (3.4 per 1000 births), of which 431 (65%) were preterm. Significant interactions were observed for maternal age, ethnicity, IMD, BMI, parity, smoking, PAPP-A, gestational hypertension, pre-eclampsia and gestational diabetes but not for chronic hypertension and pre-existing diabetes. Stronger associations with term stillbirth were observed in women with obesity compared to BMI 18.5–24.9 kg/m<sup>2</sup> (BMI 30.0–34.9 kg/m<sup>2</sup> term adjusted OR 2.1 [95% CI 1.4–3.0] vs. preterm aOR 1.1 [0.8–1.7]; BMI ≥ 35.0 kg/m<sup>2</sup> term aOR 2.2 [1.4–3.4] vs. preterm aOR 1.5 [1.2–1.8]; <i>p</i>-interaction < 0.01), nulliparity compared to parity 1 (term aOR 1.7 [1.1–2.7] vs. preterm aOR 1.2 [0.9–1.6]; <i>p</i>-interaction < 0.01) and Asian ethnicity compared with White (<i>p</i>-interaction < 0.01). A weaker or lack of association with term, compared to preterm, stillbirth was observed for older maternal age, smoking and pre-eclampsia.</p> </section> <section> <h3> Conclusion</h3> <p>Differences in association exist between mothers experiencing preterm and term stillbirth. These differences could contribute to design of timely surveillance and interventions to
目的确定与死胎相关的孕产妇和妊娠特征在早产和足月死胎之间是否存在差异.设计DESiGN RCT的二次队列分析.设置英国13家产科医院.人群足月孕妇及其婴儿.方法使用多重逻辑回归评估所探讨的12个因素是否与死胎相关。结果共纳入 195 344 名孕妇。有 667 例死胎(每 1000 例分娩中有 3.4 例),其中 431 例(65%)为早产儿。观察到产妇年龄、种族、IMD、体重指数、胎次、吸烟、PAPP-A、妊娠高血压、子痫前期和妊娠糖尿病之间存在显著的交互作用,但慢性高血压和原有糖尿病之间不存在交互作用。与 BMI 18.5-24.9 kg/m2 相比,肥胖妇女与足月死胎的关系更密切(BMI 30.0-34.9 kg/m2 足月调整 OR 2.1 [95% CI 1.4-3.0] vs. 早产 aOR 1.1 [0.8-1.7];BMI ≥ 35.0 kg/m2 足月 aOR 2.2 [1.4-3.4] vs. 早产 aOR 1.5 [1.2-1.8]; p-交互作用 < 0.01),无产褥期 vs. 产褥期 1(足月 aOR 1.7 [1.1-2.7] vs. 早产 aOR 1.2 [0.9-1.6]; p-交互作用 < 0.01),亚裔 vs. 白人(p-交互作用 < 0.01)。与早产相比,高龄产妇、吸烟和先兆子痫与足月死胎的关联较弱或缺乏关联。这些差异有助于设计及时的监测和干预措施,以进一步降低死胎风险。
{"title":"Differences in Factors Associated With Preterm and Term Stillbirth: A Secondary Cohort Analysis of the DESiGN Trial","authors":"Chivon Winsloe,&nbsp;James Elhindi,&nbsp;Matias C. Vieira,&nbsp;Sophie Relph,&nbsp;Charles G. Arcus,&nbsp;Alessandro Alagna,&nbsp;Annette Briley,&nbsp;Mark Johnson,&nbsp;Louise M. Page,&nbsp;Andrew Shennan,&nbsp;Baskaran Thilaganathan,&nbsp;Neil Marlow,&nbsp;Christoph Lees,&nbsp;Deborah A. Lawlor,&nbsp;Asma Khalil,&nbsp;Jane Sandall,&nbsp;Andrew Copas,&nbsp;Dharmintra Pasupathy,&nbsp;the DESiGN Trial team","doi":"10.1111/1471-0528.17951","DOIUrl":"10.1111/1471-0528.17951","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To identify whether maternal and pregnancy characteristics associated with stillbirth differ between preterm and term stillbirth.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Secondary cohort analysis of the DESiGN RCT.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Thirteen UK maternity units.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Singleton pregnant women and their babies.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Multiple logistic regression was used to assess whether the 12 factors explored were associated with stillbirth. Interaction tests assessed for a difference in these associations between the preterm and term periods.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measure&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Stillbirth stratified by preterm (&lt;37&lt;sup&gt;+0&lt;/sup&gt; weeks') and term (37&lt;sup&gt;+0&lt;/sup&gt;–42&lt;sup&gt;+6&lt;/sup&gt; weeks') births.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A total of 195 344 pregnancies were included. Six hundred and sixty-seven were stillborn (3.4 per 1000 births), of which 431 (65%) were preterm. Significant interactions were observed for maternal age, ethnicity, IMD, BMI, parity, smoking, PAPP-A, gestational hypertension, pre-eclampsia and gestational diabetes but not for chronic hypertension and pre-existing diabetes. Stronger associations with term stillbirth were observed in women with obesity compared to BMI 18.5–24.9 kg/m&lt;sup&gt;2&lt;/sup&gt; (BMI 30.0–34.9 kg/m&lt;sup&gt;2&lt;/sup&gt; term adjusted OR 2.1 [95% CI 1.4–3.0] vs. preterm aOR 1.1 [0.8–1.7]; BMI ≥ 35.0 kg/m&lt;sup&gt;2&lt;/sup&gt; term aOR 2.2 [1.4–3.4] vs. preterm aOR 1.5 [1.2–1.8]; &lt;i&gt;p&lt;/i&gt;-interaction &lt; 0.01), nulliparity compared to parity 1 (term aOR 1.7 [1.1–2.7] vs. preterm aOR 1.2 [0.9–1.6]; &lt;i&gt;p&lt;/i&gt;-interaction &lt; 0.01) and Asian ethnicity compared with White (&lt;i&gt;p&lt;/i&gt;-interaction &lt; 0.01). A weaker or lack of association with term, compared to preterm, stillbirth was observed for older maternal age, smoking and pre-eclampsia.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Differences in association exist between mothers experiencing preterm and term stillbirth. These differences could contribute to design of timely surveillance and interventions to","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"89-98"},"PeriodicalIF":4.7,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17951","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142245525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England COVID-19 妊娠期疫苗安全性,一项针对 2021 年 4 月至 2022 年 3 月期间英国新生儿的嵌套病例对照研究
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-16 DOI: 10.1111/1471-0528.17949
Anna A. Mensah, Julia Stowe, Jennifer E. Jardine, Freja C. M. Kirsebom, Tom Clare, Meaghan Kall, Helen Campbell, Jamie Lopez-Bernal, Nick Andrews

Objective

Assessment of COVID-19 vaccine safety in pregnancy using population-based data.

Design

Matched case–control study nested in a retrospective cohort.

Setting

April 2021–March 2022, England.

Population or Sample

All pregnant individuals aged between 18 and 50 years with valid health records.

Methods

Individuals identified from the national Maternity Services Data Set (MSDS) had their records linked to hospital admission, national COVID-19 vaccine and COVID-19 testing databases. Matching included participant's age and estimated week of conception. We compared outcomes across multiple COVID-19 vaccine exposures using conditional multivariable logistic regression, adjusting for demographic and health characteristics.

Main Outcome Measures

Adverse pregnancy, maternal and neonatal outcomes.

Results

514 013 individuals were included. We found lower odds of giving birth to a baby who was low birthweight (aOR = 0.86, 95% CI: 0.79–0.93), preterm (aOR = 0.89, 95% CI: 0.85–0.92) or who had an Apgar score < 7 at 5 min of age (aOR = 0.89, 95% CI: 0.80–0.98) for individuals who received at least one dose of COVID-19 vaccine during pregnancy. The odds of admission to intensive care unit during pregnancy were lower in those vaccinated (aOR = 0.85, 95% CI: 0.76–0.95). There was no association between vaccination in pregnancy and stillbirth, neonatal death, perinatal death and maternal venous thromboembolism in pregnancy.

Conclusions

COVID-19 vaccines are safe to use in pregnancy. Our findings generated important information to communicate to pregnant individuals and health professionals to support COVID-19 maternal vaccination programmes.

利用人群数据评估 COVID-19 疫苗在孕期的安全性。
{"title":"COVID-19 Vaccine Safety in Pregnancy, A Nested Case–Control Study in Births From April 2021 to March 2022, England","authors":"Anna A. Mensah,&nbsp;Julia Stowe,&nbsp;Jennifer E. Jardine,&nbsp;Freja C. M. Kirsebom,&nbsp;Tom Clare,&nbsp;Meaghan Kall,&nbsp;Helen Campbell,&nbsp;Jamie Lopez-Bernal,&nbsp;Nick Andrews","doi":"10.1111/1471-0528.17949","DOIUrl":"10.1111/1471-0528.17949","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Assessment of COVID-19 vaccine safety in pregnancy using population-based data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Matched case–control study nested in a retrospective cohort.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>April 2021–March 2022, England.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Population or Sample</h3>\u0000 \u0000 <p>All pregnant individuals aged between 18 and 50 years with valid health records.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Individuals identified from the national Maternity Services Data Set (MSDS) had their records linked to hospital admission, national COVID-19 vaccine and COVID-19 testing databases. Matching included participant's age and estimated week of conception. We compared outcomes across multiple COVID-19 vaccine exposures using conditional multivariable logistic regression, adjusting for demographic and health characteristics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome Measures</h3>\u0000 \u0000 <p>Adverse pregnancy, maternal and neonatal outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>514 013 individuals were included. We found lower odds of giving birth to a baby who was low birthweight (aOR = 0.86, 95% CI: 0.79–0.93), preterm (aOR = 0.89, 95% CI: 0.85–0.92) or who had an Apgar score &lt; 7 at 5 min of age (aOR = 0.89, 95% CI: 0.80–0.98) for individuals who received at least one dose of COVID-19 vaccine during pregnancy. The odds of admission to intensive care unit during pregnancy were lower in those vaccinated (aOR = 0.85, 95% CI: 0.76–0.95). There was no association between vaccination in pregnancy and stillbirth, neonatal death, perinatal death and maternal venous thromboembolism in pregnancy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>COVID-19 vaccines are safe to use in pregnancy. Our findings generated important information to communicate to pregnant individuals and health professionals to support COVID-19 maternal vaccination programmes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 13","pages":"1882-1893"},"PeriodicalIF":4.7,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17949","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142234107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Child Marriage and Adolescent Childbearing on Hysterectomy Among Married Women in India: A Cross-Sectional and Time-to-Event Analysis. 童婚和青春期生育对印度已婚妇女子宫切除术的影响:印度已婚妇女子宫切除术对童婚和青春期生育的影响:一项横断面和时间事件分析。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-06 DOI: 10.1111/1471-0528.17950
Biplab Kumar Datta, Ashwini Tiwari

Objective: Child marriage forces a girl into adult roles before physical and psychological maturity, which can take a toll on women's health over the life course. This article aims to assess whether child marriage and adolescent childbearing are associated with elevated risk of gynaecologic disorders leading to hysterectomy.

Design: Cross-sectional and time-to-event analysis.

Setting: India.

Population: 528 816 ever-married women, aged 20-49 years.

Methods: Women were grouped in four mutually exclusive categories: (i) married adult-not an adolescent mother (reference category), (ii) married adult-adolescent mother, (iii) married child-not an adolescent mother and (iv) married child-adolescent mother. Multivariable logistic regressions were fitted to assess the odds of hysterectomy for these groups. Nonparametric Kaplan-Meier survivor functions were estimated to evaluate survival rates across the groups.

Main outcome measures: Whether had a hysterectomy and age when hysterectomy was performed.

Results: Compared to women married as adults, not an adolescent mother, women married in childhood and gave birth in adolescence were 1.87 (95% CI: 1.78-1.96) times more likely to have a hysterectomy. The latter group also had the lowest survival probability for hysterectomy at all ages (e.g., 85.80% [95% CI: 85.41-86.18] at age 49 years as compared to 91.65% [95% CI: 91.37-91.89] for the former group). Women married as children but not adolescent mothers and married as an adult but gave birth in adolescence also had higher odds of hysterectomy-1.40 (95% CI: 1.31-1.50) and 1.53 (95% CI: 1.40-1.66) times of that of the reference group, respectively.

Conclusions: Our results, showing a strong relationship between child marriage and hysterectomy, contribute to the literature on later-life health consequences of child marriage.

目的童婚迫使女孩在生理和心理成熟之前就扮演成人角色,这可能会对女性一生的健康造成损害。本文旨在评估童婚和青春期生育是否与导致子宫切除术的妇科疾病风险升高有关:背景:印度:地点:印度:528 816 名 20-49 岁的已婚妇女:将妇女分为四个相互排斥的类别:(i) 已婚成年人-非青春期母亲(参考类别),(ii) 已婚成年人-青春期母亲,(iii) 已婚儿童-非青春期母亲,(iv) 已婚儿童-青春期母亲。通过多变量逻辑回归来评估这些组别的子宫切除几率。对非参数 Kaplan-Meier 存活函数进行估算,以评估各组别的存活率:是否进行过子宫切除术以及进行子宫切除术时的年龄:结果:与成年时结婚、非青春期母亲的女性相比,童年时结婚、青春期生育的女性切除子宫的几率是前者的1.87倍(95% CI:1.78-1.96)。后者在所有年龄段切除子宫的存活概率也最低(例如,49 岁时为 85.80% [95% CI:85.41-86.18],而前者为 91.65% [95% CI:91.37-91.89])。儿童时期结婚但未成为青春期母亲的妇女和成年后结婚但在青春期生育的妇女切除子宫的几率也较高,分别是参照组的 1.40 倍(95% CI:1.31-1.50)和 1.53 倍(95% CI:1.40-1.66):我们的研究结果表明,童婚与子宫切除术之间存在密切关系,为有关童婚对后半生健康影响的文献做出了贡献。
{"title":"Role of Child Marriage and Adolescent Childbearing on Hysterectomy Among Married Women in India: A Cross-Sectional and Time-to-Event Analysis.","authors":"Biplab Kumar Datta, Ashwini Tiwari","doi":"10.1111/1471-0528.17950","DOIUrl":"https://doi.org/10.1111/1471-0528.17950","url":null,"abstract":"<p><strong>Objective: </strong>Child marriage forces a girl into adult roles before physical and psychological maturity, which can take a toll on women's health over the life course. This article aims to assess whether child marriage and adolescent childbearing are associated with elevated risk of gynaecologic disorders leading to hysterectomy.</p><p><strong>Design: </strong>Cross-sectional and time-to-event analysis.</p><p><strong>Setting: </strong>India.</p><p><strong>Population: </strong>528 816 ever-married women, aged 20-49 years.</p><p><strong>Methods: </strong>Women were grouped in four mutually exclusive categories: (i) married adult-not an adolescent mother (reference category), (ii) married adult-adolescent mother, (iii) married child-not an adolescent mother and (iv) married child-adolescent mother. Multivariable logistic regressions were fitted to assess the odds of hysterectomy for these groups. Nonparametric Kaplan-Meier survivor functions were estimated to evaluate survival rates across the groups.</p><p><strong>Main outcome measures: </strong>Whether had a hysterectomy and age when hysterectomy was performed.</p><p><strong>Results: </strong>Compared to women married as adults, not an adolescent mother, women married in childhood and gave birth in adolescence were 1.87 (95% CI: 1.78-1.96) times more likely to have a hysterectomy. The latter group also had the lowest survival probability for hysterectomy at all ages (e.g., 85.80% [95% CI: 85.41-86.18] at age 49 years as compared to 91.65% [95% CI: 91.37-91.89] for the former group). Women married as children but not adolescent mothers and married as an adult but gave birth in adolescence also had higher odds of hysterectomy-1.40 (95% CI: 1.31-1.50) and 1.53 (95% CI: 1.40-1.66) times of that of the reference group, respectively.</p><p><strong>Conclusions: </strong>Our results, showing a strong relationship between child marriage and hysterectomy, contribute to the literature on later-life health consequences of child marriage.</p>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing Postpartum Venous Thromboembolism With Low-Molecular-Weight Heparin: The PP-HEP Pilot Randomised Controlled Trial 用低分子量肝素预防产后静脉血栓栓塞:PP-HEP 试点随机对照试验。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-05 DOI: 10.1111/1471-0528.17943
Marc Blondon, Marine Claver, Emilienne Celetta, Marc Righini, Begoña Martinez de Tejada
<div> <section> <h3> Objective</h3> <p>Uncertainty surrounds the risk–benefit of low-molecular-weight heparin to prevent postpartum venous thromboembolism (VTE). Data from randomised clinical trials (RCT) are critically needed, but recent feasibility studies in North America yielded low participation rates, with <1 enrolment per month per centre. Our aim was to assess the feasibility of a trial of postpartum short-term enoxaparin in Europe.</p> </section> <section> <h3> Design</h3> <p>Pragmatic, open-label pilot randomised controlled trial (RCT).</p> </section> <section> <h3> Setting</h3> <p>Swiss tertiary hospital.</p> </section> <section> <h3> Population</h3> <p>Postpartum women, within 48 h of delivery, deemed at intermediate risk of VTE with at least one major risk factor (morbid obesity, thrombophilia, emergency caesarean section, pre-eclampsia, preterm delivery, intrauterine growth restriction or systemic peripartum infection) and/or at least two minor risk factors.</p> </section> <section> <h3> Methods</h3> <p>Participants were randomised to enoxaparin 40–60 mg once daily for 10 days or no treatment, with a 90-day follow-up.</p> </section> <section> <h3> Main Outcome Measures</h3> <p>Participation rate and study acceptance (randomised participants among women in whom informed consent was sought).</p> </section> <section> <h3> Results</h3> <p>Recruitment was open for 25 weeks in 2022. Among 1504 postpartum women, 480 were eligible and 77 were randomised. The recruitment rate was 3.1 per week (13.3 per month) and the study acceptance was 23.8%. At 3 months, there was no VTE event, but one major, one nonmajor obstetrical bleeding and one surgical site complication, all in the enoxaparin group.</p> </section> <section> <h3> Conclusions</h3> <p>This pilot RCT of postpartum thromboprophylaxis set in Switzerland yielded greater participation rate and acceptance than previous attempts in North America. It calls for a large, international, collaborative trial to guide this important clinical decision.</p> </section> <section> <h3> Trial Registration</h3>
目的:低分子量肝素预防产后静脉血栓栓塞症(VTE)的风险与收益之间存在不确定性。目前急需随机临床试验(RCT)的数据,但最近在北美进行的可行性研究的参与率较低:设计:务实、开放标签试点随机对照试验(RCT):地点:瑞士三级医院:人群:产后 48 小时内,被视为 VTE 中危产妇,至少有一个主要危险因素(病态肥胖、血栓性疾病、紧急剖腹产、先兆子痫、早产、宫内生长受限或全身性围产期感染)和/或至少两个次要危险因素:参与者被随机分配到依诺肝素(enoxaparin)40-60 毫克,每天一次,为期 10 天或不治疗,随访 90 天:主要结果测量指标:参与率和研究接受度(征得知情同意的妇女中的随机参与者):结果:2022 年的招募工作持续了 25 周。在 1504 名产后妇女中,480 人符合条件,77 人被随机选中。招募率为每周 3.1 人(每月 13.3 人),研究接受率为 23.8%。3 个月后,依诺肝素组未发生 VTE 事件,但发生了一起大出血、一起非大出血和一起手术部位并发症:这项在瑞士进行的产后血栓预防试点 RCT 比之前在北美进行的尝试获得了更高的参与率和接受度。因此,需要开展一项大型的国际合作试验,为这一重要的临床决策提供指导:试验注册:ClinicalTrial.gov identifier:试验注册:ClinicalTrial.gov 标识符:NCT05878899 和 NCT04153760。
{"title":"Preventing Postpartum Venous Thromboembolism With Low-Molecular-Weight Heparin: The PP-HEP Pilot Randomised Controlled Trial","authors":"Marc Blondon,&nbsp;Marine Claver,&nbsp;Emilienne Celetta,&nbsp;Marc Righini,&nbsp;Begoña Martinez de Tejada","doi":"10.1111/1471-0528.17943","DOIUrl":"10.1111/1471-0528.17943","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Uncertainty surrounds the risk–benefit of low-molecular-weight heparin to prevent postpartum venous thromboembolism (VTE). Data from randomised clinical trials (RCT) are critically needed, but recent feasibility studies in North America yielded low participation rates, with &lt;1 enrolment per month per centre. Our aim was to assess the feasibility of a trial of postpartum short-term enoxaparin in Europe.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Pragmatic, open-label pilot randomised controlled trial (RCT).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Swiss tertiary hospital.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Postpartum women, within 48 h of delivery, deemed at intermediate risk of VTE with at least one major risk factor (morbid obesity, thrombophilia, emergency caesarean section, pre-eclampsia, preterm delivery, intrauterine growth restriction or systemic peripartum infection) and/or at least two minor risk factors.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Participants were randomised to enoxaparin 40–60 mg once daily for 10 days or no treatment, with a 90-day follow-up.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Participation rate and study acceptance (randomised participants among women in whom informed consent was sought).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Recruitment was open for 25 weeks in 2022. Among 1504 postpartum women, 480 were eligible and 77 were randomised. The recruitment rate was 3.1 per week (13.3 per month) and the study acceptance was 23.8%. At 3 months, there was no VTE event, but one major, one nonmajor obstetrical bleeding and one surgical site complication, all in the enoxaparin group.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This pilot RCT of postpartum thromboprophylaxis set in Switzerland yielded greater participation rate and acceptance than previous attempts in North America. It calls for a large, international, collaborative trial to guide this important clinical decision.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Trial Registration&lt;/h3&gt;\u0000 \u0000 ","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"35-43"},"PeriodicalIF":4.7,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17943","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A call to action to address the maternal health crisis in Nigeria 呼吁采取行动,解决尼日利亚的孕产妇健康危机。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-22 DOI: 10.1111/1471-0528.17903
Charles Anawo Ameh, Olufemi T. Oladapo, Aris T. Papageorghiou
<p>In the tapestry of global health challenges, few issues evoke as much urgency as the crisis of maternal and newborn health in low-resource settings. Nowhere is this challenge more pronounced than in Nigeria, where the struggle for accessible, quality healthcare resonates across its diverse landscape. Against the backdrop of staggering population statistics, the need for concerted action and innovative solutions becomes ever more pressing.</p><p>Nigeria with a population of over 200 million, grapples with an ongoing maternal mortality crisis that stretches logic and conscience, despite being endowed with vast human and natural resources. The risk of perinatal death in Nigeria is also unacceptably high, with no significant change recorded in the last 20 years.<span><sup>1-4</sup></span> Nigeria makes the second highest contribution of 12% of global maternal deaths, stillbirths and neonatal deaths, and is amongst the top 10 countries with the highest perinatal mortality globally.<span><sup>2</sup></span> These figures do not only pose a serious challenge to the attainment of the first target of the third sustainable development goal: behind these stark figures lie the untold stories of countless families, whose hopes and dreams are shattered by the cruel realities of inadequate healthcare access. Their struggles underscore the urgent need for increased political will, application of evidence-based interventions, and comprehensive healthcare reform to achieve universal health coverage.</p><p>To address the poor quality of care and high perinatal mortality in Nigeria, the Maternal and Perinatal Database for Quality, Equity, and Dignity Programme (MPD-4-QED) was established by the World Health Organization (WHO) and the Nigerian Federal Ministry of Health in 2019.<span><sup>5</sup></span> The aim of the programme was to facilitate the largest, periodic analysis on the quality and outcomes of care provided to women and their newborns in Nigerian referral-level hospitals to inform policy and programmatic decisions at national, subnational and facility levels.<span><sup>6</sup></span></p><p>In this <i>Special Issue</i> of BJOG we turn our attention to this critical issue of maternity care in Nigeria. In a series of articles, many of which represent analyses of the MPD-4-QED Programme, the authors examine the multifaceted complexities of maternal healthcare delivery in this African nation. The articles address diverse challenges from early pregnancy loss and preterm birth, hypertensive disorders, obstructed labour, postpartum haemorrhage, birth asphyxia and caesarean section, to neonatal jaundice and sepsis. The mission is clear: to shed light on the challenges, explore potential interventions, and pave the way for meaningful change.</p><p>Through rigorous epidemiological research and insightful analyses, the contributors undertake a detailed analysis of Nigeria's maternal and perinatal health crisis. From the underutilization of primary health centres,
在全球卫生挑战中,很少有问题能像低资源环境下的孕产妇和新生儿健康危机一样紧迫。这一挑战在尼日利亚最为突出,在尼日利亚,为获得高质量的医疗保健服务而进行的斗争在其多样化的土地上引起了共鸣。尼日利亚拥有 2 亿多人口,尽管拥有丰富的人力和自然资源,但其孕产妇死亡危机仍在持续发酵,令人费解。1-4 在全球孕产妇死亡、死胎和新生儿死亡人数中,尼日利亚占 12%,位居第二,是全球围产期死亡率最高的前 10 个国家之一。这些数字不仅对实现第三个可持续发展目标的第一项具体目标构成了严峻挑战:在这些严酷的数字背后,还隐藏着无数家庭不为人知的故事,他们的希望和梦想因医疗保健服务不足的残酷现实而破灭。为了解决尼日利亚护理质量差和围产期死亡率高的问题,世界卫生组织(WHO)和尼日利亚联邦卫生部于 2019 年建立了 "孕产妇和围产期质量、公平和尊严数据库计划"(MPD-4-QED)。5 该计划的目的是促进对尼日利亚转诊医院为产妇及其新生儿提供的护理质量和结果进行最大规模的定期分析,为国家、国家以下和医疗机构层面的政策和计划决策提供依据。在本期《BJOG》特刊中,我们将关注尼日利亚孕产妇护理的这一关键问题。在一系列文章(其中许多是对 MPD-4-QED 计划的分析)中,作者们探讨了这个非洲国家孕产妇医疗保健服务的多方面复杂性。这些文章探讨了从早孕和早产、高血压疾病、难产、产后出血、分娩窒息和剖腹产到新生儿黄疸和败血症等各种挑战。本书的使命很明确:揭示挑战,探索潜在的干预措施,为有意义的变革铺平道路。通过严谨的流行病学研究和深刻的分析,撰稿人详细分析了尼日利亚的孕产妇和围产期健康危机。从初级保健中心利用率不足、院内护理质量问题和系统性延误的严峻现实,到文化信仰障碍和社会经济差异,每篇文章都从独特的角度阐述了孕妇和新生儿所面临的错综复杂的挑战。总之,这些文章探讨了尼日利亚在改善孕产妇和新生儿预后方面取得进展的途径,敦促利益相关者响应行动号召,采用数据驱动的解决方案。本特刊发表于《尼日利亚医学杂志》(BJOG)上的一系列文章,汲取了尼日利亚濒临死亡和孕产妇死亡调查(Nigeria Near-Miss and Maternal Death Survey)7 的观点,至今已有 5 年。我们衷心希望本期特刊的推出将促进加强健康教育和意识,投资医疗保健基础设施,促进持续研究、监测和评估。要扭转孕产妇和围产期死亡的趋势,让每一位妇女和儿童都能得到应有的关爱和支持,需要知识、合作和坚定的承诺。这需要政策制定者、医疗服务提供者、研究人员和社区的共同努力。我们必须以公平、同情和团结的原则为指导,坚定不移地向前迈进。国际社会慎重努力,汇聚资源,降低尼日利亚异常高的孕产妇和围产期死亡 率,是为孕妇和新生儿实现梦寐以求的可持续发展目标的第一步。
{"title":"A call to action to address the maternal health crisis in Nigeria","authors":"Charles Anawo Ameh,&nbsp;Olufemi T. Oladapo,&nbsp;Aris T. Papageorghiou","doi":"10.1111/1471-0528.17903","DOIUrl":"10.1111/1471-0528.17903","url":null,"abstract":"&lt;p&gt;In the tapestry of global health challenges, few issues evoke as much urgency as the crisis of maternal and newborn health in low-resource settings. Nowhere is this challenge more pronounced than in Nigeria, where the struggle for accessible, quality healthcare resonates across its diverse landscape. Against the backdrop of staggering population statistics, the need for concerted action and innovative solutions becomes ever more pressing.&lt;/p&gt;&lt;p&gt;Nigeria with a population of over 200 million, grapples with an ongoing maternal mortality crisis that stretches logic and conscience, despite being endowed with vast human and natural resources. The risk of perinatal death in Nigeria is also unacceptably high, with no significant change recorded in the last 20 years.&lt;span&gt;&lt;sup&gt;1-4&lt;/sup&gt;&lt;/span&gt; Nigeria makes the second highest contribution of 12% of global maternal deaths, stillbirths and neonatal deaths, and is amongst the top 10 countries with the highest perinatal mortality globally.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; These figures do not only pose a serious challenge to the attainment of the first target of the third sustainable development goal: behind these stark figures lie the untold stories of countless families, whose hopes and dreams are shattered by the cruel realities of inadequate healthcare access. Their struggles underscore the urgent need for increased political will, application of evidence-based interventions, and comprehensive healthcare reform to achieve universal health coverage.&lt;/p&gt;&lt;p&gt;To address the poor quality of care and high perinatal mortality in Nigeria, the Maternal and Perinatal Database for Quality, Equity, and Dignity Programme (MPD-4-QED) was established by the World Health Organization (WHO) and the Nigerian Federal Ministry of Health in 2019.&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; The aim of the programme was to facilitate the largest, periodic analysis on the quality and outcomes of care provided to women and their newborns in Nigerian referral-level hospitals to inform policy and programmatic decisions at national, subnational and facility levels.&lt;span&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;In this &lt;i&gt;Special Issue&lt;/i&gt; of BJOG we turn our attention to this critical issue of maternity care in Nigeria. In a series of articles, many of which represent analyses of the MPD-4-QED Programme, the authors examine the multifaceted complexities of maternal healthcare delivery in this African nation. The articles address diverse challenges from early pregnancy loss and preterm birth, hypertensive disorders, obstructed labour, postpartum haemorrhage, birth asphyxia and caesarean section, to neonatal jaundice and sepsis. The mission is clear: to shed light on the challenges, explore potential interventions, and pave the way for meaningful change.&lt;/p&gt;&lt;p&gt;Through rigorous epidemiological research and insightful analyses, the contributors undertake a detailed analysis of Nigeria's maternal and perinatal health crisis. From the underutilization of primary health centres,","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 S3","pages":"3-4"},"PeriodicalIF":4.7,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17903","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Procedural abortion, provider-initiated preterm delivery and survival in pregnant people with cancer: A population-based cohort study 癌症孕妇的程序性流产、提供者引发的早产和存活率:基于人群的队列研究。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-21 DOI: 10.1111/1471-0528.17937
Amy Metcalfe, Zoe F. Cairncross, Joel G. Ray, Lorraine Shack, Gregg Nelson, Christine M. Friedenreich, Khokan Sikdar, Sarka Lisonkova, Carly A. McMorris, Parveen Bhatti, Deshayne B. Fell

Objective

To assess whether procedural-induced abortion or provider-initiated preterm delivery are associated with improved survival in pregnant people with cancer.

Design

Retrospective population-based cohort study.

Setting

Provinces of Alberta and Ontario, Canada, 2003–2016.

Population

Females aged 18–50 years diagnosed with cancer at <20 weeks' (for the assessment of procedural-induced abortion) or <37 weeks' gestation (for the assessment of provider-initiated delivery).

Methods

Cox proportional hazard models assessed all-cause mortality in relation to procedural-induced abortion and provider-initiated preterm delivery, adjusting for cancer site, stage at diagnosis and age. Meta-analysis pooled the results across both provinces.

Main Outcome Measures

All cause mortality.

Results

There were 512 pregnant people diagnosed with cancer at <20 weeks' gestation and 782 diagnosed with cancer at <37 weeks' gestation. Neither procedural-induced abortion (adjusted hazard ratio [aHR] = 1.39, 95% CI: 0.32–6.17) nor provider-initiated preterm delivery (aHR = 1.17, 95% CI: 0.76–1.81) were associated with improved survival following adjustment for age, stage at diagnosis and cancer site.

Conclusions

Neither procedural-induced abortion nor provider-initiated preterm birth was associated with improved survival in pregnant people diagnosed with cancer; however, these obstetric interventions are highly personal decisions best decided by the pregnant person in consultation with their care providers.

目的评估程序性流产或提供者引发的早产是否与癌症孕妇生存率的提高有关:设计:基于人群的回顾性队列研究:背景:加拿大艾伯塔省和安大略省,2003-2016年:方法:Cox 比例危险模型评估妊娠期癌症患者的生存率:Cox比例危险模型评估了与程序性流产和提供者引发的早产有关的全因死亡率,并对癌症部位、诊断分期和年龄进行了调整。Meta 分析汇总了两个省份的结果:主要结果测量:全因死亡率:结论:共有 512 名孕妇确诊患有癌症:程序性人工流产和医疗服务提供者引发的早产都与确诊癌症孕妇生存率的提高无关;然而,这些产科干预措施是高度个人化的决定,最好由孕妇与医疗服务提供者协商决定。
{"title":"Procedural abortion, provider-initiated preterm delivery and survival in pregnant people with cancer: A population-based cohort study","authors":"Amy Metcalfe,&nbsp;Zoe F. Cairncross,&nbsp;Joel G. Ray,&nbsp;Lorraine Shack,&nbsp;Gregg Nelson,&nbsp;Christine M. Friedenreich,&nbsp;Khokan Sikdar,&nbsp;Sarka Lisonkova,&nbsp;Carly A. McMorris,&nbsp;Parveen Bhatti,&nbsp;Deshayne B. Fell","doi":"10.1111/1471-0528.17937","DOIUrl":"10.1111/1471-0528.17937","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To assess whether procedural-induced abortion or provider-initiated preterm delivery are associated with improved survival in pregnant people with cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Retrospective population-based cohort study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>Provinces of Alberta and Ontario, Canada, 2003–2016.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Population</h3>\u0000 \u0000 <p>Females aged 18–50 years diagnosed with cancer at &lt;20 weeks' (for the assessment of procedural-induced abortion) or &lt;37 weeks' gestation (for the assessment of provider-initiated delivery).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Cox proportional hazard models assessed all-cause mortality in relation to procedural-induced abortion and provider-initiated preterm delivery, adjusting for cancer site, stage at diagnosis and age. Meta-analysis pooled the results across both provinces.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome Measures</h3>\u0000 \u0000 <p>All cause mortality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were 512 pregnant people diagnosed with cancer at &lt;20 weeks' gestation and 782 diagnosed with cancer at &lt;37 weeks' gestation. Neither procedural-induced abortion (adjusted hazard ratio [aHR] = 1.39, 95% CI: 0.32–6.17) nor provider-initiated preterm delivery (aHR = 1.17, 95% CI: 0.76–1.81) were associated with improved survival following adjustment for age, stage at diagnosis and cancer site.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Neither procedural-induced abortion nor provider-initiated preterm birth was associated with improved survival in pregnant people diagnosed with cancer; however, these obstetric interventions are highly personal decisions best decided by the pregnant person in consultation with their care providers.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"81-88"},"PeriodicalIF":4.7,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17937","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addition of nitrous oxide and oxygen to carbon dioxide pneumoperitoneum during laparoscopic surgery for pain reduction: A double-blinded randomized controlled trial 在腹腔镜手术二氧化碳腹腔积气中加入一氧化二氮和氧气以减轻疼痛:双盲随机对照试验。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-20 DOI: 10.1111/1471-0528.17939
Jasper Verguts, Eline Soors, Ina Callebaut, Stefan Evers, Jeroen Vandenbrande, Angelique Ceulemans, Wouter Smeets, Layth Al Tmimi, Björn Stessel

Objective

To examine if peritoneal conditioning with an altered insufflation gas mixture is associated with reduced postoperative pain intensity compared to the standard insufflation gas (i.e., 100% CO2).

Design

A prospective, single-centre, randomized, double-blind, superiority trial was performed.

Setting

This study was conducted between 4 April 2019 and 10 February 2022 at the Jessa Hospital, Hasselt, Belgium.

Population

Patients scheduled for elective gynaecologic laparoscopic surgery.

Methods

Seventy-four patients scheduled for elective gynaecologic laparoscopic surgery were randomised to receive either the standard insufflation gas with 100 CO2 (n = 37; control group) or the altered gas mixture of 86% CO2, 10% N2O and 4% O2 (n = 37; experimental group).

Main Outcome Measures

Postoperative pain was assessed at 4, 8 and 24 hours after surgery and on postoperative day (POD) 7 by an 11-point Numeric Rating Scale, with 0 indicating no pain and 10 indicating worst imaginable pain.

Results

No significant differences were found between the control and experimental groups regarding postoperative pain at 4, 8 and 24 h after surgery, as well as on POD7. In addition, the median (25% and 75%) total amount of IV piritramide consumption during the first 24 h after surgery was not significantly different between groups (control group: 18.0 [10.0, 27.0] mg vs. experimental group: 17.0 [10.0, 34.0] mg, p = 0.62).

Conclusion

The alternative insufflation gas mixture comprising 86% CO2, 10% N2O and 4% O2 used for the pneumoperitoneum during gynaecologic laparoscopic surgery does not appear to reduce postoperative pain compared to the standard insufflation gas of 100% CO2.

目的研究与标准充气气体(即100%二氧化碳)相比,使用改变的充气混合气体进行腹膜调节是否能降低术后疼痛强度:前瞻性、单中心、随机、双盲、优越性试验:本研究于2019年4月4日至2022年2月10日期间在比利时哈瑟尔特的杰萨医院进行:方法:74名计划接受妇科腹腔镜手术的患者:74名计划接受妇科腹腔镜手术的患者随机接受100 CO2的标准充气气体(n = 37;对照组)或86% CO2、10% N2O和4% O2的改变气体混合物(n = 37;实验组):术后疼痛在术后 4、8 和 24 小时以及术后第 7 天(POD)进行评估,采用 11 点数字评分量表,0 表示无疼痛,10 表示可想象到的最严重疼痛:对照组和实验组在术后 4、8 和 24 小时以及术后第 7 天的疼痛方面没有发现明显差异。对照组:18.0 [10.0, 27.0] 毫克,实验组:17.0 [10.0, 27.0] 毫克:17.0 [10.0, 34.0] mg,p = 0.62):结论:妇科腹腔镜手术中用于腹腔积气的由86% CO2、10% N2O和4% O2组成的混合充气气体与100% CO2的标准充气气体相比,似乎并不能减轻术后疼痛。
{"title":"Addition of nitrous oxide and oxygen to carbon dioxide pneumoperitoneum during laparoscopic surgery for pain reduction: A double-blinded randomized controlled trial","authors":"Jasper Verguts,&nbsp;Eline Soors,&nbsp;Ina Callebaut,&nbsp;Stefan Evers,&nbsp;Jeroen Vandenbrande,&nbsp;Angelique Ceulemans,&nbsp;Wouter Smeets,&nbsp;Layth Al Tmimi,&nbsp;Björn Stessel","doi":"10.1111/1471-0528.17939","DOIUrl":"10.1111/1471-0528.17939","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To examine if peritoneal conditioning with an altered insufflation gas mixture is associated with reduced postoperative pain intensity compared to the standard insufflation gas (i.e., 100% CO<sub>2</sub>).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>A prospective, single-centre, randomized, double-blind, superiority trial was performed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>This study was conducted between 4 April 2019 and 10 February 2022 at the Jessa Hospital, Hasselt, Belgium.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Population</h3>\u0000 \u0000 <p>Patients scheduled for elective gynaecologic laparoscopic surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Seventy-four patients scheduled for elective gynaecologic laparoscopic surgery were randomised to receive either the standard insufflation gas with 100 CO<sub>2</sub> (<i>n</i> = 37; control group) or the altered gas mixture of 86% CO<sub>2</sub>, 10% N<sub>2</sub>O and 4% O<sub>2</sub> (<i>n</i> = 37; experimental group).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome Measures</h3>\u0000 \u0000 <p>Postoperative pain was assessed at 4, 8 and 24 hours after surgery and on postoperative day (POD) 7 by an 11-point Numeric Rating Scale, with 0 indicating no pain and 10 indicating worst imaginable pain.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>No significant differences were found between the control and experimental groups regarding postoperative pain at 4, 8 and 24 h after surgery, as well as on POD7. In addition, the median (25% and 75%) total amount of IV piritramide consumption during the first 24 h after surgery was not significantly different between groups (control group: 18.0 [10.0, 27.0] mg vs. experimental group: 17.0 [10.0, 34.0] mg, <i>p</i> = 0.62).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The alternative insufflation gas mixture comprising 86% CO<sub>2</sub>, 10% N<sub>2</sub>O and 4% O<sub>2</sub> used for the pneumoperitoneum during gynaecologic laparoscopic surgery does not appear to reduce postoperative pain compared to the standard insufflation gas of 100% CO<sub>2</sub>.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"27-34"},"PeriodicalIF":4.7,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of treatment for early gestational diabetes mellitus on neonatal respiratory distress: A secondary analysis of the TOBOGM study. 早期妊娠糖尿病治疗对新生儿呼吸窘迫的影响:TOBOGM 研究的二次分析。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-19 DOI: 10.1111/1471-0528.17938
David Simmons, Jincy Immanuel, William M Hague, Suzette Coat, Helena Teede, Christopher J Nolan, Michael J Peek, Jeff R Flack, Mark McLean, Vincent W Wong, Emily J Hibbert, Alexandra Kautzky-Willer, Jürgen Harreiter, Helena Backman, Emily Gianatti, Arianne Sweeting, Viswanathan Mohan, N Wah Cheung

Objective: To identify factors associated with neonatal respiratory distress (NRD) in early Gestational diabetes mellitus (eGDM).

Design: Nested case-control analysis of the TOBOGM trial.

Setting: Seventeen hospitals: Australia, Sweden, Austria and India.

Population: Pregnant women, <20 weeks' gestation, singleton, GDM risk factors.

Methods: Women with GDM risk factors completed an oral glucose tolerance test (OGTT) before 20 weeks: those with eGDM (WHO-2013 criteria) were randomised to immediate or deferred GDM treatment. Logistic regression compared pregnancies with/without NRD, and in pregnancies with NRD, those with/without high-dependency nursery admission for ≤24 h with those admitted for >24 h. Comparisons were adjusted for age, pre-pregnancy body mass index, ethnicity, smoking, primigravity, education and site. Adjusted odds ratios (95% CI) are reported.

Main outcome measures: NRD definition: ≥4 h of respiratory support (supplemental oxygen or supported ventilation) postpartum. Respiratory distress syndrome (RDS): Supported ventilation and ≥24 h nursery stay.

Results: Ninety-nine (12.5%) of 793 infants had NRD; incidence halved (0.50, 0.31-0.79) if GDM treatment was started early. NRD was associated with Caesarean section (2.31, 1.42-3.76), large for gestational age (LGA) (1.83, 1.09-3.08) and shorter gestation (0.95, 0.93-0.97 per day longer). Among NRD infants, >24 h nursery-stay was associated with higher OGTT 1-h glucose (1.38, 1.08-1.76 per mmol/L). Fifteen (2.0%) infants had RDS.

Conclusions: Identifying and treating eGDM reduces NRD risk. NRD is more likely with Caesarean section, LGA and shorter gestation. Further studies are needed to understand the mechanisms behind this eGDM complication and any long-term effects.

目的确定与早期妊娠糖尿病(eGDM)新生儿呼吸窘迫(NRD)相关的因素:设计:TOBOGM 试验的嵌套病例对照分析:17家医院人群: 孕妇:孕妇有 GDM 危险因素的妇女在 20 周前完成口服葡萄糖耐量试验(OGTT):有 eGDM(WHO-2013 标准)的妇女被随机分配到立即或推迟 GDM 治疗。逻辑回归比较了有/无 NRD 的孕妇,以及在有 NRD 的孕妇中,有/无入托时间≤24 小时与入托时间>24 小时的孕妇。报告了调整后的几率比(95% CI):NRD 定义:产后呼吸支持(补充氧气或支持通气)≥4 小时。呼吸窘迫综合征(RDS):支持通气且在育婴室停留≥24小时:结果:793 名婴儿中有 99 名(12.5%)患有 NRD;如果及早开始治疗 GDM,发病率将减半(0.50, 0.31-0.79)。NRD与剖腹产(2.31,1.42-3.76)、胎龄偏大(LGA)(1.83,1.09-3.08)和妊娠期缩短(0.95,每天延长0.93-0.97)有关。在 NRD 婴儿中,护理时间超过 24 小时与 OGTT 1 小时血糖较高有关(1.38,1.08-1.76/mmol/L)。15名婴儿(2.0%)患有RDS:结论:识别并治疗 eGDM 可降低 NRD 风险。结论:识别并治疗 eGDM 可降低 NRD 风险。剖腹产、LGA 和较短的妊娠期更易发生 NRD。需要进一步研究以了解 eGDM 并发症背后的机制及其长期影响。
{"title":"Effect of treatment for early gestational diabetes mellitus on neonatal respiratory distress: A secondary analysis of the TOBOGM study.","authors":"David Simmons, Jincy Immanuel, William M Hague, Suzette Coat, Helena Teede, Christopher J Nolan, Michael J Peek, Jeff R Flack, Mark McLean, Vincent W Wong, Emily J Hibbert, Alexandra Kautzky-Willer, Jürgen Harreiter, Helena Backman, Emily Gianatti, Arianne Sweeting, Viswanathan Mohan, N Wah Cheung","doi":"10.1111/1471-0528.17938","DOIUrl":"https://doi.org/10.1111/1471-0528.17938","url":null,"abstract":"<p><strong>Objective: </strong>To identify factors associated with neonatal respiratory distress (NRD) in early Gestational diabetes mellitus (eGDM).</p><p><strong>Design: </strong>Nested case-control analysis of the TOBOGM trial.</p><p><strong>Setting: </strong>Seventeen hospitals: Australia, Sweden, Austria and India.</p><p><strong>Population: </strong>Pregnant women, <20 weeks' gestation, singleton, GDM risk factors.</p><p><strong>Methods: </strong>Women with GDM risk factors completed an oral glucose tolerance test (OGTT) before 20 weeks: those with eGDM (WHO-2013 criteria) were randomised to immediate or deferred GDM treatment. Logistic regression compared pregnancies with/without NRD, and in pregnancies with NRD, those with/without high-dependency nursery admission for ≤24 h with those admitted for >24 h. Comparisons were adjusted for age, pre-pregnancy body mass index, ethnicity, smoking, primigravity, education and site. Adjusted odds ratios (95% CI) are reported.</p><p><strong>Main outcome measures: </strong>NRD definition: ≥4 h of respiratory support (supplemental oxygen or supported ventilation) postpartum. Respiratory distress syndrome (RDS): Supported ventilation and ≥24 h nursery stay.</p><p><strong>Results: </strong>Ninety-nine (12.5%) of 793 infants had NRD; incidence halved (0.50, 0.31-0.79) if GDM treatment was started early. NRD was associated with Caesarean section (2.31, 1.42-3.76), large for gestational age (LGA) (1.83, 1.09-3.08) and shorter gestation (0.95, 0.93-0.97 per day longer). Among NRD infants, >24 h nursery-stay was associated with higher OGTT 1-h glucose (1.38, 1.08-1.76 per mmol/L). Fifteen (2.0%) infants had RDS.</p><p><strong>Conclusions: </strong>Identifying and treating eGDM reduces NRD risk. NRD is more likely with Caesarean section, LGA and shorter gestation. Further studies are needed to understand the mechanisms behind this eGDM complication and any long-term effects.</p>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142001260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outpatient Hysteroscopy 门诊宫腔镜检查:(Green-top 指南第 59 号)。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-19 DOI: 10.1111/1471-0528.17907
Prathiba M. De Silva, Paul P. Smith, Natalie A. M. Cooper, T. Justin Clark, the Royal College of Obstetricians and Gynaecologists
<div> <section> <div> <div> <p> </p><ul> <li>All gynaecology departments should provide a dedicated outpatient hysteroscopy service to aid care of women and people with abnormal uterine bleeding, reproductive problems, and insertion/retrieval of intrauterine devices. [Grade A]</li> <li>Written information should be provided to the woman prior to their appointment. This should include details about the procedure, the benefits and risks, advice regarding pre-operative analgesia, as well as alternative options for care and contact details for the hysteroscopy unit. [Good Practice Point]</li> <li>Women should be made aware of other settings and modes of anaesthesia for hysteroscopy (e.g. under general or regional anaesthesia or intravenous sedation). [GPP]</li> <li>The woman should be advised that if they find the procedure too painful or distressing at any point, they must alert the clinical team who will stop the procedure immediately. The clinical team should alert the hysteroscopist if the woman appears to be in too much pain or is experiencing a vasovagal episode and therefore unable to voice the concerns so that the procedure can be stopped. [GPP]</li> <li>Women should be advised to take standard doses of oral non-steroidal anti-inflammatory agents (NSAIDs) one hour before their scheduled appointment.</li> <li>Vaginoscopy should be the standard technique for outpatient hysteroscopy unless the use of a vaginal speculum is required (e.g. for administering local cervical anaesthesia or dilating the cervix). [Grade A]</li> <li>When performing operative hysteroscopy, the smallest diameter hysteroscope should be used, with consideration given to the use of hysteroscopes with expandable outer working channels because they are associated with less pain. [Grade B]</li> <li>Mechanical hysteroscopic tissue removal systems should be preferred over miniature bipolar electrodes to remove endometrial polyps. [Grade A]</li> <li>Local anaesthesia should not be routinely administered prior to outpatient hysteroscopy where a vaginoscopic approach is used. It should be considered where use of a vaginal speculum is planned e.g. for cervical dila
所有妇科部门都应提供专门的宫腔镜门诊服务,以帮助护理异常子宫出血、生殖问题和宫内节育器插入/取出的妇女和患者。[A 级] 应在预约前向妇女提供书面信息。其中应包括手术的详细信息、益处和风险、术前镇痛建议、其他护理方案以及宫腔镜检查室的详细联系方式。[良好操作规范要点] 应让妇女了解宫腔镜检查的其他麻醉环境和方式(如全身麻醉、区域麻醉或静脉镇静)。[一般原则和规范] 应告知妇女,如果她们在任何时候发现手术过程过于疼痛或痛苦,必须提醒临床团队,临床团队将立即停止手术。如果妇女感到过于疼痛或出现血管迷走发作,因而无法表达自己的担忧,临床团队应提醒宫腔镜医师,以便停止手术。[GPP] 应建议妇女在预约前一小时口服标准剂量的非甾体抗炎药(NSAIDs)。阴道镜检查应作为门诊宫腔镜检查的标准技术,除非需要使用阴道窥器(例如进行局部宫颈麻醉或扩张宫颈)。[A 级] 在进行宫腔镜手术时,应使用直径最小的宫腔镜,并考虑使用外工作通道可扩张的宫腔镜,因为这种宫腔镜疼痛较轻。[B 级] 在切除子宫内膜息肉时,应首选机械宫腔镜组织切除系统,而不是微型双极电极。[A 级] 采用阴道镜方法的门诊宫腔镜检查前,不应常规进行局部麻醉。如果计划使用阴道窥器,例如由于宫颈狭窄和/或使用直径较大的宫腔镜(外径≥5毫米)而预计需要扩张宫颈,则应考虑使用局部麻醉。[A 级] 应尽可能以最低压力灌注生理盐水,以获得满意的视野。[A 级] 不应在门诊宫腔镜手术中常规使用镇静剂。[B 级]。
{"title":"Outpatient Hysteroscopy","authors":"Prathiba M. De Silva,&nbsp;Paul P. Smith,&nbsp;Natalie A. M. Cooper,&nbsp;T. Justin Clark,&nbsp;the Royal College of Obstetricians and Gynaecologists","doi":"10.1111/1471-0528.17907","DOIUrl":"10.1111/1471-0528.17907","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;div&gt;\u0000 \u0000 &lt;div&gt;\u0000 &lt;p&gt;\u0000 \u0000 &lt;/p&gt;&lt;ul&gt;\u0000 \u0000 \u0000 &lt;li&gt;All gynaecology departments should provide a dedicated outpatient hysteroscopy service to aid care of women and people with abnormal uterine bleeding, reproductive problems, and insertion/retrieval of intrauterine devices. [Grade A]&lt;/li&gt;\u0000 \u0000 \u0000 &lt;li&gt;Written information should be provided to the woman prior to their appointment. This should include details about the procedure, the benefits and risks, advice regarding pre-operative analgesia, as well as alternative options for care and contact details for the hysteroscopy unit. [Good Practice Point]&lt;/li&gt;\u0000 \u0000 \u0000 &lt;li&gt;Women should be made aware of other settings and modes of anaesthesia for hysteroscopy (e.g. under general or regional anaesthesia or intravenous sedation). [GPP]&lt;/li&gt;\u0000 \u0000 \u0000 &lt;li&gt;The woman should be advised that if they find the procedure too painful or distressing at any point, they must alert the clinical team who will stop the procedure immediately. The clinical team should alert the hysteroscopist if the woman appears to be in too much pain or is experiencing a vasovagal episode and therefore unable to voice the concerns so that the procedure can be stopped. [GPP]&lt;/li&gt;\u0000 \u0000 \u0000 &lt;li&gt;Women should be advised to take standard doses of oral non-steroidal anti-inflammatory agents (NSAIDs) one hour before their scheduled appointment.&lt;/li&gt;\u0000 \u0000 \u0000 &lt;li&gt;Vaginoscopy should be the standard technique for outpatient hysteroscopy unless the use of a vaginal speculum is required (e.g. for administering local cervical anaesthesia or dilating the cervix). [Grade A]&lt;/li&gt;\u0000 \u0000 \u0000 &lt;li&gt;When performing operative hysteroscopy, the smallest diameter hysteroscope should be used, with consideration given to the use of hysteroscopes with expandable outer working channels because they are associated with less pain. [Grade B]&lt;/li&gt;\u0000 \u0000 \u0000 &lt;li&gt;Mechanical hysteroscopic tissue removal systems should be preferred over miniature bipolar electrodes to remove endometrial polyps. [Grade A]&lt;/li&gt;\u0000 \u0000 \u0000 &lt;li&gt;Local anaesthesia should not be routinely administered prior to outpatient hysteroscopy where a vaginoscopic approach is used. It should be considered where use of a vaginal speculum is planned e.g. for cervical dila","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 13","pages":"e86-e110"},"PeriodicalIF":4.7,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17907","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The placenta and umbilical cord in prenatal care: Unseen, overlooked and misunderstood 产前护理中的胎盘和脐带:看不见、忽视和误解。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-14 DOI: 10.1111/1471-0528.17936
Eric Jauniaux, Christoph Lees, Amar Bhide, Elizabeth Daly-Jones, Deepa Srinivasan, Yinka Oyelese
<p>The prenatal diagnosis of placental anomalies was one of the first use of ultrasound imaging in obstetrics from the end of the 1960s.<span><sup>1, 2</sup></span> Conditions such as placenta praevia and hydatidiform mole had been known for centuries to be associated with a high maternal morbidity and mortality, when undiagnosed before labour for placenta praevia or when presenting with severe anaemia and eclampsia for a hydatidiform mole. Previous attempts at imaging the placenta in utero included soft tissue radiography with radioactive isotopes injected into the maternal circulation or the amniotic cavity and pelvic angiography using radio-opaque dyes injected into the femoral artery.</p><p>Ultrasound imaging rapidly proved more practical and safer than radiology techniques as it did not expose both mother and fetus to radiation. Rapid improvements in ultrasound resolution over the following decade made it possible to diagnose major fetal anomalies such as spina bifida,<span><sup>3</sup></span> and a decade later, with the development of colour Doppler imaging, it became possible to accurately identification of small fetal vessels such as vasa praevia.<span><sup>4</sup></span></p><p>Placenta praevia was originally defined using transabdominal sonography (TAS) as a placenta developing within the lower uterine segment and graded according to the relationship between the lowest placental edge and the internal cervical os.<span><sup>5</sup></span> The use of high-resolution transvaginal ultrasound (TVS) has revolutionised the diagnosis and follow-up of placenta praevia by allowing accurate measurements of the distance between the presenting placental edge or vasa praevia and the internal os.<span><sup>6, 7</sup></span> TVS has proven safe in patients suspected of having a placenta praevia on transabdominal ultrasound<span><sup>6</sup></span> and the majority of pregnant patients in the UK who have TVS reported finding the experience acceptable.<span><sup>7</sup></span></p><p>Overall, ultrasound imaging has changed the management and outcome of patients presenting with fetal congenital defects, abnormal fetal growth, multiple pregnancies and maternal obstetric disorders such as pre-eclampsia and gestational diabetes, and has led to the development of the subspeciality in materno-fetal medicine (MFM). Similarly, sonographers have become specialised in obstetric scanning. However, during this process, detailed ultrasound examination of the placenta and the umbilical cord has been left behind and is only superficially included in obstetric ultrasound training programmes.<span><sup>8</sup></span> Furthermore, hyper-specialisation in fetal medicine scanning has limited the exposure of both MFM and sonographer trainees to the use of TVS, which is mainly used in gynaecology and in the evaluation of patients with early pregnancy complications in specialised gynaecology clinics and early pregnancy units. In the present commentary, we address these issues a
胎盘异常的产前诊断是20世纪60年代末超声成像在产科的第一个应用。1,2几个世纪以来,人们一直认为前置胎盘和葡萄胎等疾病与产妇的高发病率和死亡率有关,如果在分娩前未确诊为前置胎盘或出现严重贫血和子痫时为葡萄胎。以前对子宫胎盘成像的尝试包括将放射性同位素注入母体循环或羊膜腔的软组织x线摄影和将放射性不透明染料注入股动脉的盆腔血管摄影。超声成像很快被证明比放射技术更实用、更安全,因为它不会使母亲和胎儿都暴露在辐射中。在接下来的十年中,超声分辨率的快速提高使得诊断脊柱裂等主要胎儿异常成为可能,10年后,随着彩色多普勒成像的发展,准确识别胎儿小血管(如前置血管)成为可能。4前置胎盘最初是通过经腹超声(TAS)定义为在子宫下部段发育的胎盘,并根据胎盘最低边缘与宫颈内壁的关系进行分级高分辨率阴道超声(TVS)的使用彻底改变了前置胎盘的诊断和随访,允许准确测量呈现胎盘边缘或前置血管与内部os之间的距离。经腹部超声检查,TVS已被证明对怀疑患有前置胎盘的患者是安全的,英国大多数患有TVS的孕妇报告说,他们认为这种经历是可以接受的。总的来说,超声成像已经改变了胎儿先天性缺陷、胎儿生长异常、多胎妊娠和产妇产科疾病(如先兆子痫和妊娠糖尿病)患者的治疗和结果,并导致了母胎医学亚专科(MFM)的发展。同样,超声医师也成为产科扫描的专业人员。然而,在这一过程中,对胎盘和脐带的详细超声检查被抛在后面,只是表面上被纳入产科超声培训方案此外,胎儿医学扫描的高度专业化限制了MFM和超声检查受训人员使用TVS的机会,TVS主要用于妇科和专科妇科诊所和早孕单位对早孕并发症患者的评估。在本评论中,我们讨论了这些问题以及将胎盘和脐带检查纳入国家产科超声成像培训方案的必要性。随着剖腹产(CD)数量的增加和人工生殖技术(ART)的使用,特别是体外受精(IVF)的使用,前置胎盘和增生前置胎盘的发病率在世界范围内呈指数增长。5,8然而,英国国家筛查委员会(UK NSC)从未推荐过前置胎盘的国家筛查方案,目前也没有系统的胎盘增生谱筛查方案。英国国家医疗服务体系胎儿异常筛查计划(FASP)于2023年5月4日更新,声明,在妊娠中期常规扫描(妊娠18+ 0-20 +6周)检查胎盘位置和羊水不是NHS英格兰FASP的一部分,但是良好的临床实践(https://www.gov.uk/guidance/fetal-anomaly-screening-programme-overview).The 2021年国家健康和护理卓越研究所(NICE)建议为所有怀孕患者提供胎儿异常筛查,并在妊娠中期常规扫描中确定胎盘位置(https://www.nice.org.uk/guidance/ng201)。然而,它不建议使用超声检查技术的标准化方案,也不建议使用胎龄进行随访检查。十年前,尤妮斯·肯尼迪·施莱弗国家儿童健康与人类发展研究所、母胎医学学会、美国超声医学研究所、美国妇产科学会、美国放射学会、儿科放射学会和放射科学会联合发布的执行摘要建议,“前置胎盘”一词仅在胎盘直接位于子宫内部时使用对于妊娠16周的孕妇,当胎盘边缘距离内腹20毫米时,应报告胎盘“低垂”;当胎盘边缘距离内腹20毫米或以上时,应报告胎盘正常。 如果在分娩前未确诊,VP与55%的围产期死亡率和幸存者长期神经发育障碍的高风险相关有针对性的筛查高危患者(体外受精妊娠或有VCI或低胎盘)已被证明可以有效降低VP12的死亡率和发病率,并在许多西方国家的指南中推荐进行一般筛查。在英国,英国国家安全委员会2023年6月的审查建议不进行副流行性腮腺炎筛查,因为不知道英国有多少婴儿受到影响,筛查的准确性如何,并且存在不必要的早期乳糜泻和假阴性病例的风险。(https://www.view-health-screening-recommendations.service.gov.uk/vasa-praevia)。这一建议是基于一家私人承包商(Costello Medical Consulting Ltd;www.costellomedical.cpm),不包括对高危患者进行针对性筛查的讨论。胎盘和脐带的异常可以很容易地在产前20周的详细胎儿超声检查中筛查出来,出生前的诊断最有可能预防母亲和婴儿的围产期发病率和死亡率。对许多产科超声课程和培训方案进行了简短的网上搜索,没有找到在线课程或实践课程,其中包括专门检查胎盘或脐带的课程。它也不是产科超声医师或MFM专科培训的一部分,除了一个粗略的提及。为了减少这些异常对妊娠结果的影响,有必要将这一主题纳入MFM和产科超声医师课程,并使用标准化的协议来报告这些情况,包括使用TVS。所有作者都对这篇评注的构思和写作做出了贡献。本研究未获资助。作者报告没有利益冲突,没有。
{"title":"The placenta and umbilical cord in prenatal care: Unseen, overlooked and misunderstood","authors":"Eric Jauniaux,&nbsp;Christoph Lees,&nbsp;Amar Bhide,&nbsp;Elizabeth Daly-Jones,&nbsp;Deepa Srinivasan,&nbsp;Yinka Oyelese","doi":"10.1111/1471-0528.17936","DOIUrl":"10.1111/1471-0528.17936","url":null,"abstract":"&lt;p&gt;The prenatal diagnosis of placental anomalies was one of the first use of ultrasound imaging in obstetrics from the end of the 1960s.&lt;span&gt;&lt;sup&gt;1, 2&lt;/sup&gt;&lt;/span&gt; Conditions such as placenta praevia and hydatidiform mole had been known for centuries to be associated with a high maternal morbidity and mortality, when undiagnosed before labour for placenta praevia or when presenting with severe anaemia and eclampsia for a hydatidiform mole. Previous attempts at imaging the placenta in utero included soft tissue radiography with radioactive isotopes injected into the maternal circulation or the amniotic cavity and pelvic angiography using radio-opaque dyes injected into the femoral artery.&lt;/p&gt;&lt;p&gt;Ultrasound imaging rapidly proved more practical and safer than radiology techniques as it did not expose both mother and fetus to radiation. Rapid improvements in ultrasound resolution over the following decade made it possible to diagnose major fetal anomalies such as spina bifida,&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; and a decade later, with the development of colour Doppler imaging, it became possible to accurately identification of small fetal vessels such as vasa praevia.&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Placenta praevia was originally defined using transabdominal sonography (TAS) as a placenta developing within the lower uterine segment and graded according to the relationship between the lowest placental edge and the internal cervical os.&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; The use of high-resolution transvaginal ultrasound (TVS) has revolutionised the diagnosis and follow-up of placenta praevia by allowing accurate measurements of the distance between the presenting placental edge or vasa praevia and the internal os.&lt;span&gt;&lt;sup&gt;6, 7&lt;/sup&gt;&lt;/span&gt; TVS has proven safe in patients suspected of having a placenta praevia on transabdominal ultrasound&lt;span&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt; and the majority of pregnant patients in the UK who have TVS reported finding the experience acceptable.&lt;span&gt;&lt;sup&gt;7&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Overall, ultrasound imaging has changed the management and outcome of patients presenting with fetal congenital defects, abnormal fetal growth, multiple pregnancies and maternal obstetric disorders such as pre-eclampsia and gestational diabetes, and has led to the development of the subspeciality in materno-fetal medicine (MFM). Similarly, sonographers have become specialised in obstetric scanning. However, during this process, detailed ultrasound examination of the placenta and the umbilical cord has been left behind and is only superficially included in obstetric ultrasound training programmes.&lt;span&gt;&lt;sup&gt;8&lt;/sup&gt;&lt;/span&gt; Furthermore, hyper-specialisation in fetal medicine scanning has limited the exposure of both MFM and sonographer trainees to the use of TVS, which is mainly used in gynaecology and in the evaluation of patients with early pregnancy complications in specialised gynaecology clinics and early pregnancy units. In the present commentary, we address these issues a","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"12-14"},"PeriodicalIF":4.7,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17936","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bjog-An International Journal of Obstetrics and Gynaecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1